 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Akero Therapeutics Inc. (AKRO)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-07-01 Sale | 2020-07-06 7:00 pm | Akero Therapeutics Inc. | AKRO | venBio Global Strategic Fund II L.P. venBio Global Strategic GP II L.P. venBio Global Strategic GP II Ltd. Adelman Robert J GOODMAN COREY S 10% Owner | 116,467 | $34.4 | $4,006,537 | 3,033,552 (Indirect) | View |
| 2020-01-02 Sale(A) | 2020-07-10 8:28 pm | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 72,444 | $19.7 | $1,427,272 | 2,899,998 (Indirect) | View |
| 2020-01-07 Sale(A) | 2020-07-10 8:28 pm | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 53,057 | $19.99 | $1,060,845 | 2,846,941 (Indirect) | View |
| 2020-07-10 Purchase | 2020-07-14 4:45 pm | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner | 415,000 | $36 | $14,940,000 | 5,830,203 (Indirect) | View |
| 2020-07-10 Purchase | 2020-07-14 4:46 pm | Akero Therapeutics Inc. | AKRO | Apple Tree Partners IV L.P. ATP III GP Ltd. 10% Owner | 415,000 | $36 | $14,940,000 | 5,830,203 (Direct) | View |
| 2020-10-09 Sale | 2020-10-14 4:54 pm | Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director | 13,000 | $28.93 | $376,090 | 11,780 (Indirect) | View |
| 2021-01-04 Sale | 2021-01-06 6:48 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 3,060 | $25.29 | $77,399 | 181,785 (Indirect Direct) | View |
| 2021-01-07 Sale | 2021-01-11 7:54 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 10,000 | $28.12 | $281,200 | 179,285 (Indirect Direct) | View |
| 2021-02-01 Sale | 2021-02-02 4:08 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 3,055 | $29.24 | $89,321 | 176,230 (Indirect Direct) | View |
| 2021-03-01 Sale | 2021-03-02 5:56 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 3,055 | $30.48 | $93,112 | 173,175 (Indirect Direct) | View |
| 2021-04-01 Sale | 2021-04-05 5:14 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 50,000 | $28.64 | $1,432,166 | 2,270 (Direct) | View |
| 2021-04-01 Sale | 2021-04-05 5:15 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 3,055 | $28.75 | $87,828 | 170,120 (Indirect Direct) | View |
| 2021-05-03 Sale | 2021-05-04 4:06 pm | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 4,200 | $30.56 | $128,352 | 2,270 (Direct) | View |
| 2021-05-03 Sale | 2021-05-04 4:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 3,055 | $30.56 | $93,361 | 167,065 (Indirect Direct) | View |
| 2021-06-01 Sale | 2021-06-02 4:06 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 3,055 | $26.24 | $80,151 | 164,010 (Indirect Direct) | View |
| 2021-06-01 Sale | 2021-06-03 8:07 pm | Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director | 17,489 | $26.28 | $459,611 | 0 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-03-13 Exercise | 2020-03-16 5:51 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 5,035 | $0.615 | 177,518 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 5:51 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 6,082 | $0.615 | 183,600 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 5:51 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 5,035 | $0 | 42,796 (Direct) | View |
| 2020-03-13 Exercise | 2020-03-16 5:51 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 6,082 | $0 | 94,268 (Direct) | View |
| 2020-03-30 Exercise | 2020-04-01 6:52 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 2,168 | $19.97 | 2,168 (Direct) | View |
| 2020-03-30 Exercise | 2020-04-01 6:52 pm | N/A 2029-11-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 2,168 | $0 | 23,832 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 6:52 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director 10% Owner | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 6:53 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 6:54 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 6:54 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-01 Option Award | 2020-06-02 6:54 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-11 7:01 pm | N/A 2030-06-09 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2020-01-02 Other | 2020-07-10 8:28 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 684,143 | $0 | 2,956,590 (Indirect) | View |
| 2020-01-02 Other | 2020-07-10 8:28 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 13,683 | $0 | 13,683 (Indirect) | View |
| 2020-01-02 Other | 2020-07-10 8:28 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 13,683 | $0 | 0 (Indirect) | View |
| 2020-01-02 Other | 2020-07-10 8:28 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 11,803 | $0 | 11,803 (Indirect) | View |
| 2020-01-02 Other | 2020-07-10 8:28 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC 10% Owner | 11,803 | $0 | 0 (Indirect) | View |
| 2020-12-08 Option Award | 2020-12-09 8:47 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 1,245 | $17.07 | 327,559 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:47 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 242,500 | $0 | 242,500 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:49 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 1,245 | $17.07 | 244,178 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:49 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 77,580 | $0 | 77,580 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:50 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 1,245 | $17.07 | 164,914 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:50 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 77,580 | $0 | 77,580 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:52 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 1,245 | $17.07 | 2,270 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:52 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 77,580 | $0 | 77,580 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:53 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 1,245 | $17.07 | 184,845 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:53 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 77,580 | $0 | 77,580 (Direct) | View |
| 2020-12-21 Gift | 2020-12-23 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 50 | $0 | 327,509 (Direct) | View |
| 2020-12-21 Gift | 2020-12-23 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 2,500 | $0 | 325,009 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-23 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,500 | $0.62 | 335,509 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-23 4:19 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 10,500 | $0 | 286,192 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-29 4:53 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 7,480 | $0.62 | 342,989 (Direct) | View |
| 2020-12-28 Exercise | 2020-12-29 4:53 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 7,480 | $0 | 278,712 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 7:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 7,500 | $0.615 | 189,285 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 7:54 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Young Jonathan COO | 7,500 | $0 | 35,296 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 7:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 20,000 | $0.615 | 362,989 (Direct) | View |
| 2021-01-07 Gift | 2021-01-11 7:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 3,000 | $0 | 359,989 (Direct) | View |
| 2021-01-07 Exercise | 2021-01-11 7:57 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew CEO | 20,000 | $0 | 258,712 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-05 5:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 50,000 | $7.01 | 52,270 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-05 5:14 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 50,000 | $0 | 364,029 (Direct) | View |
| 2021-04-22 Option Award | 2021-04-26 5:09 pm | N/A 2031-04-22 | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 26,000 | $0 | 26,000 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-04 4:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 4,200 | $7.009 | 6,470 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-04 4:06 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard CFO | 4,200 | $0 | 359,829 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:55 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-06-01 Gift | 2021-06-03 5:55 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $0 | 0 (Direct) | View |
| 2021-06-01 Gift | 2021-06-03 5:55 pm | N/A 2029-11-07 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 23,832 | $0 | 0 (Direct) | View |
| 2021-06-01 Gift | 2021-06-03 5:55 pm | N/A 2030-05-31 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 13,000 | $0 | 0 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:56 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Bitterman Kevin Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:56 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:57 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:58 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:58 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-03 5:59 pm | N/A 2031-05-31 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 13,000 | $0 | 13,000 (Direct) | View |